Literature DB >> 35606089

British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.

Anjan Dhar1,2, Hasan N Haboubi3,4, Stephen E Attwood5, Marcus K H Auth6,7, Jason M Dunn8,9, Rami Sweis10, Danielle Morris11, Jenny Epstein12, Marco R Novelli13, Hannah Hunter14, Amanda Cordell15, Sharon Hall16, Jamal O Hayat17, Kapil Kapur18, Andrew Robert Moore19, Carol Read20, Sarmed S Sami21, Paul J Turner22,23, Nigel J Trudgill24.   

Abstract

BACKGROUND: Eosinophilic oesophagitis (EoE) is an increasingly common cause of dysphagia in both children and adults, as well as one of the most prevalent oesophageal diseases with a significant impact on physical health and quality of life. We have provided a single comprehensive guideline for both paediatric and adult gastroenterologists on current best practice for the evaluation and management of EoE.
METHODS: The Oesophageal Section of the British Society of Gastroenterology was commissioned by the Clinical Standards Service Committee to develop these guidelines. The Guideline Development Group included adult and paediatric gastroenterologists, surgeons, dietitians, allergists, pathologists and patient representatives. The Population, Intervention, Comparator and Outcomes process was used to generate questions for a systematic review of the evidence. Published evidence was reviewed and updated to June 2021. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system was used to assess the evidence and make recommendations. Two rounds of voting were held to assess the level of agreement and the strength of recommendations, with 80% consensus required for acceptance.
RESULTS: Fifty-seven statements on EoE presentation, diagnosis, investigation, management and complications were produced with further statements created on areas for future research.
CONCLUSIONS: These comprehensive adult and paediatric guidelines of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition are based on evidence and expert consensus from a multidisciplinary group of healthcare professionals, including patient advocates and patient support groups, to help clinicians with the management patients with EoE and its complications. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  DIET; DYSPHAGIA; ENDOSCOPY; OESOPHAGEAL DISEASE; PAEDIATRIC GASTROENTEROLOGY

Mesh:

Year:  2022        PMID: 35606089      PMCID: PMC9279848          DOI: 10.1136/gutjnl-2022-327326

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   31.793


  245 in total

1.  Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.

Authors:  Alex Straumann; Sebastien Conus; Lukas Degen; Cornelia Frei; Christian Bussmann; Christoph Beglinger; Alain Schoepfer; Hans-Uwe Simon
Journal:  Clin Gastroenterol Hepatol       Date:  2011-01-28       Impact factor: 11.382

Review 2.  Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis.

Authors:  F J Moawad; J G Cheatham; K J DeZee
Journal:  Aliment Pharmacol Ther       Date:  2013-08-05       Impact factor: 8.171

3.  Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.

Authors:  Alfredo J Lucendo; Stephan Miehlke; Christoph Schlag; Michael Vieth; Ulrike von Arnim; Javier Molina-Infante; Dirk Hartmann; Albert Jan Bredenoord; Constanza Ciriza de Los Rios; Stefan Schubert; Stefan Brückner; Ahmed Madisch; Jamal Hayat; Jan Tack; Stephen Attwood; Ralph Mueller; Roland Greinwald; Alain Schoepfer; Alex Straumann
Journal:  Gastroenterology       Date:  2019-03-26       Impact factor: 22.682

4.  Distal esophagus is the most commonly involved site for strictures in patients with eosinophilic esophagitis.

Authors:  Swathi Eluri; Manaswita Tappata; Kevin Z Huang; Nathaniel T Koutlas; Benjamin S Robey; Claire Fan; Craig C Reed; Nicholas J Shaheen; Evan S Dellon
Journal:  Dis Esophagus       Date:  2020-03-05       Impact factor: 3.429

5.  Esophageal motor abnormalities in eosinophilic esophagitis identified by high-resolution manometry.

Authors:  Leticia Martín Martín; Cecilio Santander; Mari Carmen Lopez Martín; Jorge Espinoza-Ríos; Carlos Chavarría-Herbozo; Javier P Gisbert; Ricardo Moreno-Otero
Journal:  J Gastroenterol Hepatol       Date:  2011-09       Impact factor: 4.029

6.  The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis.

Authors:  Jennifer A Nielsen; Donna J Lager; Matthew Lewin; Gabriel Rendon; Cory A Roberts
Journal:  Am J Gastroenterol       Date:  2014-01-21       Impact factor: 10.864

7.  Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury.

Authors:  Rhonda F Souza; Xiaofang Huo; Vivek Mittal; Christopher M Schuler; Susanne W Carmack; Hui Ying Zhang; Xi Zhang; Chunhua Yu; Kathy Hormi-Carver; Robert M Genta; Stuart J Spechler
Journal:  Gastroenterology       Date:  2009-08-04       Impact factor: 22.682

8.  Esophageal perforation management using a multidisciplinary minimally invasive treatment algorithm.

Authors:  Kfir Ben-David; Kevin Behrns; Steven Hochwald; Georgios Rossidis; Angel Caban; Cristina Crippen; Thomas Caranasos; Steven Hughes; Peter Draganov; Christopher Forsmark; Shailendra Chauhan; Mihir S Wagh; George Sarosi
Journal:  J Am Coll Surg       Date:  2014-01-09       Impact factor: 6.113

9.  Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.

Authors:  F J Moawad; A M Schoepfer; E Safroneeva; M R Ally; Y-J Chen; C L Maydonovitch; R K H Wong
Journal:  Aliment Pharmacol Ther       Date:  2014-01-26       Impact factor: 8.171

10.  Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods.

Authors:  James P Franciosi; Kevin A Hommel; Charles W DeBrosse; Allison B Greenberg; Alexandria J Greenler; J Pablo Abonia; Marc E Rothenberg; James W Varni
Journal:  BMC Gastroenterol       Date:  2011-11-18       Impact factor: 3.067

View more
  1 in total

Review 1.  Mechanisms and clinical management of eosinophilic oesophagitis: an overview.

Authors:  Luc Biedermann; Alex Straumann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-17       Impact factor: 73.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.